
1. Malar J. 2019 Aug 28;18(1):293. doi: 10.1186/s12936-019-2919-3.

Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium
falciparum isolates and absence of association with susceptibility to common
anti-malarial drugs.

Foguim FT(1)(2)(3), Robert MG(1)(2)(3), Gueye MW(4), Gendrot M(1)(2)(3), Diawara 
S(4), Mosnier J(1)(2)(3)(5), Amalvict R(1)(2)(3)(5), Benoit N(1)(2)(3)(5),
Bercion R(6), Fall B(4), Madamet M(1)(2)(3)(5), Pradines B(7)(8)(9)(10)(11);
French National Reference Centre for Imported Malaria Study Group.

Collaborators: Augis V, Basset D, Bastien P, Benoit-Vical F, Berry A, Brouqui P, 
Cividin M, Delaunay P, Delhaes L, Drancourt M, Gaillard T, Genin A, Garnotel E,
Javelle E, L'Ollivier C, Leveque M, Malvy D, Marty P, Mechain M, Ménard G, Millet
P, Minodier P, Mottard A, Parola P, Piarroux R, Pomares-Estran C, Receveur MC,
Robin A, Sappa E, Savini H, Simon F, Sterkers Y, Surcouf C, Varlet E, Wolff A.

Author information: 
(1)Unité Parasitologie et Entomologie, Département de Microbiologie et de
maladies infectieuses, Institut de recherche biomédicale des armées, IHU
Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.
(2)IRD, SSA, AP-HM, VITROME, Aix Marseille Université, Marseille, France.
(3)IHU Méditerranée Infection, Marseille, France.
(4)Fédération des laboratoires, Hôpital Principal de Dakar, Dakar, Senegal.
(5)Centre national de référence du Paludisme, Marseille, France.
(6)Laboratoire d'analyses médicales, Institut Pasteur de Dakar, Dakar, Senegal.
(7)Unité Parasitologie et Entomologie, Département de Microbiologie et de
maladies infectieuses, Institut de recherche biomédicale des armées, IHU
Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.
bruno.pradines@gmail.com.
(8)IRD, SSA, AP-HM, VITROME, Aix Marseille Université, Marseille, France.
bruno.pradines@gmail.com.
(9)IHU Méditerranée Infection, Marseille, France. bruno.pradines@gmail.com.
(10)Fédération des laboratoires, Hôpital Principal de Dakar, Dakar, Senegal.
bruno.pradines@gmail.com.
(11)Centre national de référence du Paludisme, Marseille, France.
bruno.pradines@gmail.com.

BACKGROUND: Resistance to all available anti-malarial drugs has emerged and
spread including artemisinin derivatives and their partner drugs. Several genes
involved in artemisinin and partner drugs resistance, such as pfcrt, pfmdr1,
pfK13 or pfpm2, have been identified. However, these genes do not properly
explain anti-malarial drug resistance, and more particularly clinical failures
observed in Africa. Mutations in genes encoding for Plasmodium falciparum
proteins, such as P. falciparum Acetyl-CoA transporter (PfACT), P. falciparum
UDP-galactose transporter (PfUGT) and P. falciparum cyclic amine resistance locus
(PfCARL) have recently been associated to resistance to imidazolopiperazines and 
other unrelated drugs.
METHODS: Mutations on pfugt, pfact and pfcarl were characterized on 86 isolates
collected in Dakar, Senegal and 173 samples collected from patients hospitalized 
in France after a travel in African countries from 2015 and 2016 to assess their 
potential association with ex vivo susceptibility to chloroquine, quinine,
lumefantrine, monodesethylamodiaquine, mefloquine, dihydroartemisinin,
artesunate, doxycycline, pyronaridine and piperaquine.
RESULTS: No mutations were found on the genes pfugt and pfact. None of the pfcarl
described mutations were identified in these samples from Africa. The K784N
mutation was found in one sample and the K734M mutation was identified on 7.9% of
all samples for pfcarl. The only significant differences in ex vivo
susceptibility according to the K734M mutation were observed for pyronaridine for
African isolates from imported malaria and for doxycycline for Senegalese
parasites.
CONCLUSION: No evidence was found of involvement of these genes in reduced
susceptibility to standard anti-malarial drugs in African P. falciparum isolates.

DOI: 10.1186/s12936-019-2919-3 
PMCID: PMC6712813
PMID: 31455301  [Indexed for MEDLINE]

